In this thesis, we focused on developing new bioinformatics algorithms with the ultimate aim of creating a better understanding of cancer. Our research targeted 3 unsolved problems. First, a main difficulty in treating cancer is that it is often unclear which mutations are present. As a result, cells with undetected mutations may escape therapy and re-grow. Our solution involves sampling from multiple regions of the tumor to capture a larger number of mutations, and constructing a tree that represents the order in which these mutations originated. Second, many cancers present with structural variants in non-coding regions, yet their function is unknown. We found that these structural variants often disrupt the folding of the genome,...
Advances in the field of molecular biology have resulted in a decent understanding of the causes for...
Tumors commonly exhibit high levels of both inter- and intra- heterogeneity. For this reason, the op...
In 2018, an estimated 1,762,450 new cases of cancer will be diagnosed in the United States and 606,8...
Cancer evolves due to changes in DNA that give a cell an advantage at the expense of the remaining o...
High-throughput genome sequencing and other techniques provide a cost-effective way to study cancer ...
High-throughput genome sequencing and other techniques provide a cost-effective way to study cancer ...
Heterogeneity is arguably one of the most important hallmarks of cancer which contributes to its dru...
The notion that DNA changes could drive the growth of cancer was first speculated more than a centur...
Cancer is a very complex genetic disease driven by combinations of mutated genes. This complexity st...
The genome of a cancer cell is replete with somatic mutations imprinted by the activities of differe...
Cancer is an umbrella terminology that binds hundreds of complex genetic diseases based on a set of ...
The genome of a cancer cell is replete with somatic mutations imprinted by the activities of differe...
Advances in the field of molecular biology have resulted in a decent understanding of the causes for...
Mutations are the driving force of evolution, yet they underlie many diseases and, in particular, ca...
Cancer research, like many areas of science, is adapting to a new era characterized by increasing qu...
Advances in the field of molecular biology have resulted in a decent understanding of the causes for...
Tumors commonly exhibit high levels of both inter- and intra- heterogeneity. For this reason, the op...
In 2018, an estimated 1,762,450 new cases of cancer will be diagnosed in the United States and 606,8...
Cancer evolves due to changes in DNA that give a cell an advantage at the expense of the remaining o...
High-throughput genome sequencing and other techniques provide a cost-effective way to study cancer ...
High-throughput genome sequencing and other techniques provide a cost-effective way to study cancer ...
Heterogeneity is arguably one of the most important hallmarks of cancer which contributes to its dru...
The notion that DNA changes could drive the growth of cancer was first speculated more than a centur...
Cancer is a very complex genetic disease driven by combinations of mutated genes. This complexity st...
The genome of a cancer cell is replete with somatic mutations imprinted by the activities of differe...
Cancer is an umbrella terminology that binds hundreds of complex genetic diseases based on a set of ...
The genome of a cancer cell is replete with somatic mutations imprinted by the activities of differe...
Advances in the field of molecular biology have resulted in a decent understanding of the causes for...
Mutations are the driving force of evolution, yet they underlie many diseases and, in particular, ca...
Cancer research, like many areas of science, is adapting to a new era characterized by increasing qu...
Advances in the field of molecular biology have resulted in a decent understanding of the causes for...
Tumors commonly exhibit high levels of both inter- and intra- heterogeneity. For this reason, the op...
In 2018, an estimated 1,762,450 new cases of cancer will be diagnosed in the United States and 606,8...